Abu Dhabi: The Abu Dhabi Biobank has launched a new private cord blood banking service to empower families with personalized medical solutions and strengthen Abu Dhabi’s life sciences sector. This service allows expectant families to preserve their newborns’ stem cells locally and at half the cost of current market rates.
The service is available through partnerships with leading Abu Dhabi healthcare facilities such as Danat Al Emarat Women’s and Children Hospital, Corniche Hospital, and Kanad Hospital. Instead of shipping samples abroad, cord blood will be stored safely in a state-of-the-art facility in Masdar City for up to 30 years, ensuring that stem cells remain viable for future therapeutic use.
Cord blood is a rich source of hematopoietic stem cells that can develop into various blood and immune system cells. These cells are vital in treating more than 80 life-threatening diseases prevalent in the UAE, such as thalassemia, sickle cell anemia, leukemia, and other genetic conditions. This local and affordable service removes financial and logistical barriers and increases the chances of finding a suitable stem cell match within families.
Paul Downey, General Manager of Abu Dhabi Biobank, explained that this launch is a strong statement towards making personalized care accessible and breaking down barriers that often leave cord blood discarded as medical waste. With flexible payment plans, advanced biobanking technology, and additional benefits like newborn screening and genetic counseling, the service aims to improve treatment outcomes and promote preventive healthcare.
Families interested in private cord blood banking can register their interest by visiting the official website at https://abudhabibiobank.ae/ or calling 800 213 to speak with an advisor.
